Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash Flows from Operating Activities:
Net income	$ 735,207	$ 664,229
Adjustments to reconcile net income to net cash used in operating activities:
Stock-based compensation expense to certain officers and directors		207,087
Interest earned on marketable securities held in Trust Account	(2,814,405)	(1,632,278)
Unrealized loss on marketable securities held in Trust Account		21,578
Benefit from income taxes	(210,152)	(4,123)
Changes in operating assets and liabilities:
Prepaid expenses	64,131	(143,822)
Prepaid insurance	25,681	(52,556)
Accrued expenses	564,544	221,709
Income taxes payable	795,704	310,848
Net cash used in operating activities	(839,290)	(407,328)
Cash Flows from Investing Activities:
Proceeds from Trust Account to pay franchise and income taxes	568,382
Investment of cash into Trust Account		(70,380,000)
Extension deposit into Trust Account	(1,380,000)
Net cash used in investing activities	(811,618)	(70,380,000)
Cash Flows from Financing Activities:
Proceeds from sale of units, net of underwriting discounts paid		67,965,000
Proceeds from sale of private placement units		3,945,000
Proceeds from promissory note - related party	1,580,000	100,085
Payment of offering costs	(75,000)	(581,635)
Net cash provided by financing activities	1,505,000	71,428,450
Net Change in Cash and Restricted Cash	(145,908)	641,122
Cash and Restricted Cash – Beginning of period	607,816	34,393
Cash and Restricted Cash – End of period	461,908	675,515
Cash and Restricted Cash, end of period
Cash	108,520	675,515
Cash – restricted	353,388
Cash and Restricted Cash – End of period	461,908	675,515
Non-Cash investing and financing activities:
Remeasurement of Class A common stock subject to redemption value	3,558,853	7,061,204
Excise tax payable	497,749
Pending redemptions of Class A common stock	49,774,936
Offering costs included in accrued offering costs		75,000
Deferred underwriting fee payable		$ 2,070,000